Medicine & Life Sciences
Enterotoxigenic Escherichia coli
100%
Shigella flexneri
94%
Vaccines
86%
Bacillary Dysentery
79%
Shigella Vaccines
77%
Diarrhea
64%
Shigella
62%
Stakeholder Participation
55%
Placebos
45%
Vaccination
39%
Stem Cells
35%
Infections
33%
Immunization
31%
Community Participation
31%
Health Care Process Assessment
30%
Cattle
29%
Serum
28%
Lipopolysaccharides
21%
Antibodies
20%
Implementation Science
18%
Immunoglobulin G
18%
Dysentery
17%
Signs and Symptoms
16%
Empowerment
15%
Ownership
14%
Organized Financing
14%
Immunity
13%
Thinking
12%
Polysaccharides
11%
Immunoglobulin A
11%
Safety
10%
Volunteers
10%
Accidental Falls
9%
Pseudomonas aeruginosa toxA protein
9%
B-Lymphocytes
9%
Escherichia coli Vaccines
9%
Colostrum
8%
Exotoxins
8%
Fever
8%
Escherichia coli Infections
7%
Proof of Concept Study
7%
Conjugate Vaccines
7%
Morbidity
7%
Hygiene
6%
Mortality
6%
Pseudomonas aeruginosa
5%
Colic
5%
Antibody Formation
5%
Immunoglobulins
5%
Child
5%
Chemical Compounds
Bioconjugate
92%
Protective
92%
Exotoxin
87%
O-Polysaccharide
84%
Lipopolysaccharide
61%
Enteric Coating
50%
Percent Reduction
43%
Safety
31%
Antimicrobial Agent
26%
Strain
25%
Effector
20%
Reduction
16%